We showed that exposure of MM cell lines to LPS, prior to treatment with BTZ, could partially protect cells from BTZ-induced apoptosis; this effect was also evident after TLR4 knockdown in myeloma cells. The gene discussed is TLR4; the disease is plasma cell myeloma.